Posted inPress Releases
Cancer Therapeutics Market Gains New Viral Therapy Option as Telomelysin Launches in Japan for Esophageal Cancer
Japan has approved the commercial use of a virus-based treatment for esophageal cancer, opening a new chapter for targeted viral approaches in oncology. Telomelysin, developed by Tokyo-based Oncolys BioPharma Inc.,…









